{"id":"W2536769127","doi":"10.1016/s1470-2045(16)30532-0","title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1086,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"Medicine; Oncology; Maintenance therapy; Clinical endpoint; Internal medicine; Systemic therapy; Radiation therapy; Lung cancer; Performance status; Progression-free survival; Targeted therapy; Chemotherapy; Cancer; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0456415097933536,"score_gpt":0.3758414789814968,"score_spread":0.3301999691881432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}